Starpharma Holdings Limited
Starpharma Holdings Limited SPHRY Peers
See (SPHRY) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SPHRY | $0.47 | -17.98% | 19.56M | -2.34 | -$0.20 | N/A |
| NONOF | $67.50 | +2.27% | 299.64B | 19.18 | $3.52 | +2.46% |
| CSLLY | $78.33 | -0.18% | 151.71B | 28.80 | $2.72 | +1.69% |
| CMXHF | $150.96 | -7.39% | 73.10B | 27.70 | $5.45 | +1.83% |
| UCBJY | $90.81 | +0.65% | 34.52B | 29.68 | $3.06 | +0.60% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJF | $175.75 | +4.21% | 33.40B | 28.72 | $6.12 | +0.74% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.14 | +0.82% | 12.47B | 27.91 | $0.22 | N/A |
| GNMSF | $199.35 | +5.59% | 12.25B | 11.69 | $17.05 | N/A |
Stock Comparison
SPHRY vs NONOF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, NONOF has a market cap of 299.64B. Regarding current trading prices, SPHRY is priced at $0.47, while NONOF trades at $67.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas NONOF's P/E ratio is 19.18. In terms of profitability, SPHRY's ROE is -0.26%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, SPHRY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CSLLY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CSLLY has a market cap of 151.71B. Regarding current trading prices, SPHRY is priced at $0.47, while CSLLY trades at $78.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CSLLY's P/E ratio is 28.80. In terms of profitability, SPHRY's ROE is -0.26%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, SPHRY is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CMXHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CMXHF has a market cap of 73.10B. Regarding current trading prices, SPHRY is priced at $0.47, while CMXHF trades at $150.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CMXHF's P/E ratio is 27.70. In terms of profitability, SPHRY's ROE is -0.26%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, SPHRY is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs UCBJY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, UCBJY has a market cap of 34.52B. Regarding current trading prices, SPHRY is priced at $0.47, while UCBJY trades at $90.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas UCBJY's P/E ratio is 29.68. In terms of profitability, SPHRY's ROE is -0.26%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, SPHRY is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ARGNF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, SPHRY is priced at $0.47, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, SPHRY's ROE is -0.26%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, SPHRY and ARGNF have similar daily volatility (0.00).
SPHRY vs UCBJF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, UCBJF has a market cap of 33.40B. Regarding current trading prices, SPHRY is priced at $0.47, while UCBJF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas UCBJF's P/E ratio is 28.72. In terms of profitability, SPHRY's ROE is -0.26%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, SPHRY and UCBJF have similar daily volatility (0.00).
SPHRY vs ODTC Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, SPHRY is priced at $0.47, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ODTC's P/E ratio is -0.08. In terms of profitability, SPHRY's ROE is -0.26%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, SPHRY and ODTC have similar daily volatility (0.00).
SPHRY vs WXXWY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, WXXWY has a market cap of 12.47B. Regarding current trading prices, SPHRY is priced at $0.47, while WXXWY trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas WXXWY's P/E ratio is 27.91. In terms of profitability, SPHRY's ROE is -0.26%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, SPHRY is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs GNMSF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, GNMSF has a market cap of 12.25B. Regarding current trading prices, SPHRY is priced at $0.47, while GNMSF trades at $199.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas GNMSF's P/E ratio is 11.69. In terms of profitability, SPHRY's ROE is -0.26%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, SPHRY is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs WXIBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, SPHRY is priced at $0.47, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, SPHRY's ROE is -0.26%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, SPHRY and WXIBF have similar daily volatility (0.00).
SPHRY vs IVBXF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, IVBXF has a market cap of 11.67B. Regarding current trading prices, SPHRY is priced at $0.47, while IVBXF trades at $7.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas IVBXF's P/E ratio is -707.54. In terms of profitability, SPHRY's ROE is -0.26%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, SPHRY is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs SBMFF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, SPHRY is priced at $0.47, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, SPHRY's ROE is -0.26%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, SPHRY is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs SBHMY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, SPHRY is priced at $0.47, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, SPHRY's ROE is -0.26%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, SPHRY is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs TRSBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, TRSBF has a market cap of 6.01B. Regarding current trading prices, SPHRY is priced at $0.47, while TRSBF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas TRSBF's P/E ratio is 28.33. In terms of profitability, SPHRY's ROE is -0.26%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, SPHRY is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs TLPPF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, TLPPF has a market cap of 5.67B. Regarding current trading prices, SPHRY is priced at $0.47, while TLPPF trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas TLPPF's P/E ratio is 186.43. In terms of profitability, SPHRY's ROE is -0.26%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, SPHRY is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ABCZF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, SPHRY is priced at $0.47, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, SPHRY and ABCZF have similar daily volatility (0.00).
SPHRY vs INCPF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, SPHRY is priced at $0.47, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas INCPF's P/E ratio is -108.67. In terms of profitability, SPHRY's ROE is -0.26%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, SPHRY and INCPF have similar daily volatility (0.00).
SPHRY vs AKBLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, SPHRY is priced at $0.47, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, SPHRY's ROE is -0.26%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, SPHRY is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs LABFF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, SPHRY is priced at $0.47, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas LABFF's P/E ratio is 28.95. In terms of profitability, SPHRY's ROE is -0.26%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, SPHRY and LABFF have similar daily volatility (0.00).
SPHRY vs ZLDPF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ZLDPF has a market cap of 4.48B. Regarding current trading prices, SPHRY is priced at $0.47, while ZLDPF trades at $63.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ZLDPF's P/E ratio is -24.49. In terms of profitability, SPHRY's ROE is -0.26%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, SPHRY is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs SHJBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, SPHRY is priced at $0.47, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, SPHRY's ROE is -0.26%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, SPHRY and SHJBF have similar daily volatility (0.00).
SPHRY vs REGMF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, REGMF has a market cap of 3.37B. Regarding current trading prices, SPHRY is priced at $0.47, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas REGMF's P/E ratio is -13.32. In terms of profitability, SPHRY's ROE is -0.26%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, SPHRY is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CAMRF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, SPHRY is priced at $0.47, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CAMRF's P/E ratio is 59.57. In terms of profitability, SPHRY's ROE is -0.26%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, SPHRY is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs GNNSF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, SPHRY is priced at $0.47, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, SPHRY's ROE is -0.26%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, SPHRY is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs TKBIF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, SPHRY is priced at $0.47, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, SPHRY's ROE is -0.26%, compared to TKBIF's ROE of N/A. Regarding short-term risk, SPHRY and TKBIF have similar daily volatility (0.00).
SPHRY vs MPSYF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, SPHRY is priced at $0.47, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, SPHRY's ROE is -0.26%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, SPHRY is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ASPHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, SPHRY is priced at $0.47, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, SPHRY's ROE is -0.26%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, SPHRY and ASPHF have similar daily volatility (0.00).
SPHRY vs BVNKF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, SPHRY is priced at $0.47, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, SPHRY's ROE is -0.26%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, SPHRY is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BVNRY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BVNRY has a market cap of 2.00B. Regarding current trading prices, SPHRY is priced at $0.47, while BVNRY trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BVNRY's P/E ratio is 10.22. In terms of profitability, SPHRY's ROE is -0.26%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, SPHRY is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BTTAY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, SPHRY is priced at $0.47, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, SPHRY's ROE is -0.26%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, SPHRY is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs MEOBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, SPHRY is priced at $0.47, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, SPHRY's ROE is -0.26%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, SPHRY is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs GLPGF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, GLPGF has a market cap of 1.81B. Regarding current trading prices, SPHRY is priced at $0.47, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas GLPGF's P/E ratio is -9.02. In terms of profitability, SPHRY's ROE is -0.26%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, SPHRY is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs GENSF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, SPHRY is priced at $0.47, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas GENSF's P/E ratio is -338.75. In terms of profitability, SPHRY's ROE is -0.26%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, SPHRY is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PPTDF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, SPHRY is priced at $0.47, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PPTDF's P/E ratio is 17.35. In terms of profitability, SPHRY's ROE is -0.26%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, SPHRY is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BRCTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BRCTF has a market cap of 1.68B. Regarding current trading prices, SPHRY is priced at $0.47, while BRCTF trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BRCTF's P/E ratio is -90.40. In terms of profitability, SPHRY's ROE is -0.26%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, SPHRY is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BIESF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BIESF has a market cap of 1.62B. Regarding current trading prices, SPHRY is priced at $0.47, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BIESF's P/E ratio is -45.71. In terms of profitability, SPHRY's ROE is -0.26%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, SPHRY and BIESF have similar daily volatility (0.00).
SPHRY vs ONTTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ONTTF has a market cap of 1.58B. Regarding current trading prices, SPHRY is priced at $0.47, while ONTTF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ONTTF's P/E ratio is -7.86. In terms of profitability, SPHRY's ROE is -0.26%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, SPHRY is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PHMMF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, SPHRY is priced at $0.47, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PHMMF's P/E ratio is 64.21. In terms of profitability, SPHRY's ROE is -0.26%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, SPHRY is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CSBTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, SPHRY is priced at $0.47, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, SPHRY and CSBTF have similar daily volatility (0.00).
SPHRY vs NURPF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, SPHRY is priced at $0.47, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas NURPF's P/E ratio is 11.63. In terms of profitability, SPHRY's ROE is -0.26%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, SPHRY is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ASCLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, SPHRY is priced at $0.47, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, SPHRY's ROE is -0.26%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, SPHRY is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CSPHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, SPHRY is priced at $0.47, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, SPHRY's ROE is -0.26%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, SPHRY is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PHGUF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PHGUF has a market cap of 680.31M. Regarding current trading prices, SPHRY is priced at $0.47, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, SPHRY and PHGUF have similar daily volatility (0.00).
SPHRY vs BPMUF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, SPHRY is priced at $0.47, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BPMUF's P/E ratio is 6.85. In terms of profitability, SPHRY's ROE is -0.26%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, SPHRY is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs INRLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, SPHRY is priced at $0.47, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas INRLF's P/E ratio is -5.16. In terms of profitability, SPHRY's ROE is -0.26%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, SPHRY and INRLF have similar daily volatility (0.00).
SPHRY vs SOLTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, SPHRY is priced at $0.47, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SOLTF's P/E ratio is -34.76. In terms of profitability, SPHRY's ROE is -0.26%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, SPHRY is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs IVEVF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, SPHRY is priced at $0.47, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, SPHRY's ROE is -0.26%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, SPHRY and IVEVF have similar daily volatility (0.00).
SPHRY vs CLTEF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, SPHRY is priced at $0.47, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, SPHRY's ROE is -0.26%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, SPHRY and CLTEF have similar daily volatility (0.00).
SPHRY vs CYDY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CYDY has a market cap of 480.65M. Regarding current trading prices, SPHRY is priced at $0.47, while CYDY trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CYDY's P/E ratio is -19.50. In terms of profitability, SPHRY's ROE is -0.26%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, SPHRY is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs VBIZF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, SPHRY is priced at $0.47, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, SPHRY's ROE is -0.26%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, SPHRY and VBIZF have similar daily volatility (0.00).
SPHRY vs SNBIF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, SPHRY is priced at $0.47, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, SPHRY's ROE is -0.26%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, SPHRY is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CKDXF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, SPHRY is priced at $0.47, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, SPHRY's ROE is -0.26%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, SPHRY is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs AAVXF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, SPHRY is priced at $0.47, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, SPHRY's ROE is -0.26%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, SPHRY and AAVXF have similar daily volatility (0.00).
SPHRY vs BXPHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BXPHF has a market cap of 449.41M. Regarding current trading prices, SPHRY is priced at $0.47, while BXPHF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BXPHF's P/E ratio is -23.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, SPHRY and BXPHF have similar daily volatility (0.00).
SPHRY vs TBGNF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, SPHRY is priced at $0.47, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, SPHRY's ROE is -0.26%, compared to TBGNF's ROE of N/A. Regarding short-term risk, SPHRY and TBGNF have similar daily volatility (0.00).
SPHRY vs NWBO Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, NWBO has a market cap of 416.93M. Regarding current trading prices, SPHRY is priced at $0.47, while NWBO trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas NWBO's P/E ratio is -4.14. In terms of profitability, SPHRY's ROE is -0.26%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, SPHRY is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs HBMHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, SPHRY is priced at $0.47, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, SPHRY's ROE is -0.26%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, SPHRY and HBMHF have similar daily volatility (0.00).
SPHRY vs PTCHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, SPHRY is priced at $0.47, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, SPHRY is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CLVLY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CLVLY has a market cap of 359.89M. Regarding current trading prices, SPHRY is priced at $0.47, while CLVLY trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CLVLY's P/E ratio is 14.65. In terms of profitability, SPHRY's ROE is -0.26%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, SPHRY is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CLVLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, SPHRY is priced at $0.47, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, SPHRY's ROE is -0.26%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, SPHRY and CLVLF have similar daily volatility (0.00).
SPHRY vs IDRSF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, IDRSF has a market cap of 337.12M. Regarding current trading prices, SPHRY is priced at $0.47, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas IDRSF's P/E ratio is -0.94. In terms of profitability, SPHRY's ROE is -0.26%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, SPHRY and IDRSF have similar daily volatility (0.00).
SPHRY vs PRRUF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, SPHRY is priced at $0.47, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, SPHRY is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BOVNF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, SPHRY is priced at $0.47, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, SPHRY's ROE is -0.26%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, SPHRY and BOVNF have similar daily volatility (0.00).
SPHRY vs NGENF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, NGENF has a market cap of 302.73M. Regarding current trading prices, SPHRY is priced at $0.47, while NGENF trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas NGENF's P/E ratio is -15.59. In terms of profitability, SPHRY's ROE is -0.26%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, SPHRY is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PBBIF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, SPHRY is priced at $0.47, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, SPHRY's ROE is -0.26%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, SPHRY is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ORYZF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, SPHRY is priced at $0.47, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, SPHRY's ROE is -0.26%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, SPHRY and ORYZF have similar daily volatility (0.00).
SPHRY vs NWPHF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, SPHRY is priced at $0.47, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas NWPHF's P/E ratio is N/A. In terms of profitability, SPHRY's ROE is -0.26%, compared to NWPHF's ROE of N/A. Regarding short-term risk, SPHRY and NWPHF have similar daily volatility (0.00).
SPHRY vs MDCLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, SPHRY is priced at $0.47, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, SPHRY's ROE is -0.26%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, SPHRY is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs HLOSF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, SPHRY is priced at $0.47, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas HLOSF's P/E ratio is -7.26. In terms of profitability, SPHRY's ROE is -0.26%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, SPHRY is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs SPHDF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, SPHRY is priced at $0.47, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SPHDF's P/E ratio is -3.99. In terms of profitability, SPHRY's ROE is -0.26%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, SPHRY is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs RAONF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, SPHRY is priced at $0.47, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas RAONF's P/E ratio is -20.33. In terms of profitability, SPHRY's ROE is -0.26%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, SPHRY is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs FPHAF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, SPHRY is priced at $0.47, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, SPHRY's ROE is -0.26%, compared to FPHAF's ROE of N/A. Regarding short-term risk, SPHRY and FPHAF have similar daily volatility (0.00).
SPHRY vs VSBC Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, SPHRY is priced at $0.47, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas VSBC's P/E ratio is N/A. In terms of profitability, SPHRY's ROE is -0.26%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, SPHRY and VSBC have similar daily volatility (0.00).
SPHRY vs FGHQF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, SPHRY is priced at $0.47, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, SPHRY's ROE is -0.26%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, SPHRY is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs HNSBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, SPHRY is priced at $0.47, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, SPHRY's ROE is -0.26%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, SPHRY is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BSEM Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BSEM has a market cap of 196.40M. Regarding current trading prices, SPHRY is priced at $0.47, while BSEM trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BSEM's P/E ratio is -21.09. In terms of profitability, SPHRY's ROE is -0.26%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, SPHRY is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs GNFTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, SPHRY is priced at $0.47, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, SPHRY's ROE is -0.26%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, SPHRY is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs SCNLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, SPHRY is priced at $0.47, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, SPHRY's ROE is -0.26%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, SPHRY and SCNLF have similar daily volatility (0.00).
SPHRY vs OPORF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, SPHRY is priced at $0.47, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas OPORF's P/E ratio is 12.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, SPHRY is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs MLLCF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, SPHRY is priced at $0.47, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MLLCF's P/E ratio is -2.09. In terms of profitability, SPHRY's ROE is -0.26%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, SPHRY is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs AVCTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, SPHRY is priced at $0.47, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, SPHRY's ROE is -0.26%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, SPHRY is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs RECEF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, SPHRY is priced at $0.47, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas RECEF's P/E ratio is -10.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, SPHRY is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs BRIBF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, SPHRY is priced at $0.47, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, SPHRY's ROE is -0.26%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, SPHRY and BRIBF have similar daily volatility (0.00).
SPHRY vs IPHYF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, SPHRY is priced at $0.47, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, SPHRY's ROE is -0.26%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, SPHRY is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs AAPGV Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, SPHRY is priced at $0.47, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas AAPGV's P/E ratio is N/A. In terms of profitability, SPHRY's ROE is -0.26%, compared to AAPGV's ROE of N/A. Regarding short-term risk, SPHRY is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PRNAF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, SPHRY is priced at $0.47, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, SPHRY's ROE is -0.26%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, SPHRY and PRNAF have similar daily volatility (0.00).
SPHRY vs AMGXF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, SPHRY is priced at $0.47, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, SPHRY's ROE is -0.26%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, SPHRY is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs PSTTF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, SPHRY is priced at $0.47, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to PSTTF's ROE of N/A. Regarding short-term risk, SPHRY and PSTTF have similar daily volatility (0.00).
SPHRY vs EPRXF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, SPHRY is priced at $0.47, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, SPHRY's ROE is -0.26%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, SPHRY is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs IUGNF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, IUGNF has a market cap of 104.54M. Regarding current trading prices, SPHRY is priced at $0.47, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas IUGNF's P/E ratio is -1.40. In terms of profitability, SPHRY's ROE is -0.26%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, SPHRY is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ADOIF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, SPHRY is priced at $0.47, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, SPHRY's ROE is -0.26%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, SPHRY and ADOIF have similar daily volatility (0.00).
SPHRY vs PBIGF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, SPHRY is priced at $0.47, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, SPHRY's ROE is -0.26%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, SPHRY is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ADOCY Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, SPHRY is priced at $0.47, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, SPHRY's ROE is -0.26%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, SPHRY and ADOCY have similar daily volatility (0.00).
SPHRY vs TRGNF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, SPHRY is priced at $0.47, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, SPHRY's ROE is -0.26%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, SPHRY is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs CMVLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, SPHRY is priced at $0.47, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, SPHRY's ROE is -0.26%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, SPHRY is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs MCURF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, SPHRY is priced at $0.47, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MCURF's P/E ratio is -16.90. In terms of profitability, SPHRY's ROE is -0.26%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, SPHRY is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs MSCLF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, MSCLF has a market cap of 82.59M. Regarding current trading prices, SPHRY is priced at $0.47, while MSCLF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas MSCLF's P/E ratio is 2.77. In terms of profitability, SPHRY's ROE is -0.26%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, SPHRY is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs ACHFF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, ACHFF has a market cap of 79.09M. Regarding current trading prices, SPHRY is priced at $0.47, while ACHFF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas ACHFF's P/E ratio is -30.00. In terms of profitability, SPHRY's ROE is -0.26%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, SPHRY is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.
SPHRY vs KNTPF Comparison
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 19.56M. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, SPHRY is priced at $0.47, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -2.34, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, SPHRY's ROE is -0.26%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, SPHRY and KNTPF have similar daily volatility (0.00).